Warning being added to cholesterol-lowering drug labels
WASHINGTON (WABC) -- The Food and Drug Administration is making changes to the labeling for some widely used cholesterol-lowering drugs known as statins.
These products, when used with diet and exercise, help to lower a person's "bad" cholesterol.
The changes to the statin labels are:
"We want health care professionals and patients to have the most current information on the risks of statins, but also to assure them that these medications continue to provide an important health benefit of lowering cholesterol," said Mary Parks, M.D., a spokesperson for the FDA.
The products include: Lipitor (atorvastatin), Lescol (fluvastatin), Mevacor (lovastatin), Altoprev (lovastatin extended-release), Livalo (pitavastatin), Pravachol (pravastatin), Crestor (rosuvastatin), and Zocor (simvastatin). Combination products include: Advicor (lovastatin/niacin extended-release), Simcor (simvastatin/niacin extended-release), and Vytorin (simvastatin/ezetimibe).
Health care professionals and patients should report any side effects associated with statin use to FDA MedWatch program.
For more information:
Get Eyewitness News Delivered
cholesterol, fda, statins, health news, dr. jay adlersberg
- Missing 11-year-old Brooklyn boy possibly found
- AccuWeather: March roller coaster
- Live: Eyewitness News on 7online streamed live!
- Get WATCH ABC for your mobile device
- Newtown shooter's father speaks out for 1st time
- Metro-North worker fatally struck by train in NYC
- 4-year closure of Tarrytown Tappan Zee ramp begins 48 min ago
- Search continues for missing plane; 2 flew on stolen passports 17 min ago
- Photos: Malaysia Airlines missing plane
- UWS street to be renamed after 4-year-old Ariel Russo
- NY-native bank robbery suspect nabbed after selfies
- UCONN sophomore accuses sorority sisters of hazing
- CT hockey referee arrested after removing child from ice
- Photos: 10 suspects caught in the act
- Search continues for missing plane; 2 flew...
17 min ago